Diploid

Curated by Signal

Provider of software to diagnose rare diseases

Overview

Provider of software to diagnose rare diseases. The company uses a proprietary machine-learning algorithm to analyze patient data generated by next-gen sequencing technologies. In addition, Diploid also runs GentleLabs, a direct-to-consumer testing company that tests saliva samples for over 1700 genetic disorders and mails the results to the customer's physicians.

Key facts

Founded: 2006
Headquarters: Leuven, Belgium
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

BISC Global
Provider of bioinformatics and biostatics services for life science companies
Life Sciences TechnologyGhent, Belgium
BrainRT
Developer of neurodiaganostics and sleep monitoring EEG based device
Life Sciences TechnologyRumst, Belgium
Biogazelle
Transcriptomics-based diagnostics and therapeutics, and qPCR software.
Life Sciences TechnologyGhent, Belgium

About Diploid

What does Diploid do?

Provider of software to diagnose rare diseases.

Where is Diploid headquartered?

Diploid is headquartered in Leuven, Belgium.

When was Diploid founded?

Diploid was founded in 2006.

Which sector is Diploid in?

Diploid operates in Life Sciences Technology.

Who are Diploid's competitors?

Companies similar to Diploid include BISC Global, BrainRT, and Biogazelle.